Chugai Pharmaceutical Co., Ltd. / Fundamentals
Income statement
- Net revenue
€6.90B - Cost of goods sold
€2.05B - Gross profit
€4.85B - SG&A expenses
€549.52M - R&D expenses
€1.06B - EBITDA
€3.35B - D&A
€152.42M - EBIT
€3.25B - Interest expenses
€0.00 - EBT
€3.21B - Tax expenses
€928.21M - Net income
€2.28B
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€99.42M - Changes in working capital
€313.10M - Operating cash flow
€2.68B - Capex
€385.68M - Other investing cash flow
-€88.94M - Net investing cash flow
-€1.10B - Total cash dividends paid
-€933.48M - Issuance of common stock
€1.06M - Debt repayment
-€11.89M - Other financing cash flow
-€33.15M - Net financing cash flow
-€977.50M - Foreign exchange effects
-€1.59M - Net change in cash
€1.27B - Cash at end of period
€2.87B - Free cash flow
€3.07B
Balance sheet
- Cash and cash equivalents
€2.87B - Cash and short-term investments
€5.94B - Total receivables
€1.83B - Inventory
€1.36B - Other current assets
€227.83M - Total current assets
€9.36B - Property, plant & equipment
€2.72B - Goodwill
€0.00 - Intangible assets
€192.32M - Long-term investments
€0.00 - Other non-current assets
€474.60M - Total non-current assets
€3.81B - Total assets
€13.16B - Accounts payable
€452.99M - Short-term debt
€0.00 - Other current liabilities
€1.10B - Total current liabilities
€1.55B - Long-term debt
€76.27M - Deferred tax liabilities
€30.14M - Other non-current liabilities
€37.68M - Total non-current liabilities
€144.09M - Total liabilities
€1.69B - Common stock
€422.86M - Retained earnings
€10.67B - Other equity
-€33.86M - Total equity
€11.47B - Total liabilities and shareholders' equity
€13.16B
Company information
- Market capitalization
€74.63B - Employees
5K - Enterprise Value
€12.11T
Company ratios
- Gross margin
-
70.3% Even with peer group: 72.9% - EBITDA margin
-
48.6% Much better than peer group: 22.7% - EBIT margin
-
47.1% Much better than peer group: 14.6% - EBT margin
-
46.6% Much better than peer group: 15.5% - Net margin
-
33.1% Much better than peer group: 12.7% - ROE
-
19.9% Better than peer group: 9.1% - ROA
-
17.4% Better than peer group: 6.1% - Asset turnover
-
52.4% Even with peer group: 50.3% - FCF margin
-
33.3% Much better than peer group: 10.7% - FCF yield
3.1% - Efficiency ratio
51.4% - Net sales per employee
-
€1.37M - Net income per employee
-
€454.55K